Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

C-Section pain relief: could a wound pump replace spinal morphine?

NCT ID NCT01211431

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a continuous infusion of numbing and anti-inflammatory drugs directly into the C-section wound can control pain as well as a standard spinal injection of morphine. The study enrolls women having a planned C-section with a single, healthy pregnancy. Researchers will compare pain scores, side effects, and the risk of long-term scar pain between the two approaches.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ropivacaine and diclofenac (wound infusion) vs. morphine (spinal injection)
What this could lead to
If the wound infusion works as well as morphine, it could offer a safer, more convenient option for post-cesarean pain relief with fewer side effects.
What could go wrong
This is a small, single-center Phase 4 trial, so results may not apply to all patients. The experimental treatment might not match morphine's effectiveness or could have its own side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Start date

Sep 2010

Expected to finish

Oct 2012

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * single, normally progressing pregancy * term \> 36 weeks amenorrhea * BMI between 20 and 25 kg/m\^2 before pregnancy * height between 55 and 90 kg * cesarean section by Joel-Cohen or Pfannenstiel techniques * patient has signed consent * patient has social security coverage Exclusion Criteria: * Multiple pregnancy * pathological pregnancy: hypertension (\>140/90 mmHg found during the pregnancy), pre-eclampsia, gestational diabetes * term \< 36 weeks amenorrhea * non-pregnancy related maternal pathology (insufficiency) * obesity (BMI \> 25 kg/m\^2 before pregnancy) * height \< 155 cm or \> 180 cm * weight \< 55 kg or \> 90 kg * patient refuses to sign consent * surgical technique other than Joel-Cohen or Pfannenstiel * hepatic insufficiency (prothrombin \< 60%) * contra-indications for rachianesthesia: infection, hemostasis problems (platelets \< 80.109/L, prothrombin \< 60%, TCA \> 40s) * allergy to local anesthestics * patient is participating in another study, or has participated in another study within the last 6 months * patient is under any type of guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean section are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.